Breast cancer is the most common cancer worldwide. The occurrence of breast cancer is
associated with many risk factors, including genetic and hereditary predisposition. Breast …

Multiple studies in the first decade of the 21st century have established contrast‐enhanced
breast MRI as a screening modality for women with a hereditary or familial increased risk for …

Early detection decreases breast cancer death. The ACR recommends annual screening
beginning at age 40 for women of average risk and earlier and/or more intensive screening …

Importance Improved screening methods for women with dense breasts are needed
because of their increased risk of breast cancer and of failed early diagnosis by screening …

Hereditary breast and ovarian cancer syndrome (HBOC) is clinically defined by family
history criteria, and molecularly defined by identification of germline pathogenic variants …

Background The best supplemental breast cancer screening modality in women at average
risk or intermediate risk for breast cancer with dense breast and negative mammogram …

In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI),
gadopentetate dimeglumine (Magnevist®), became available for clinical use. Since then, a …

Purpose We investigated whether an abbreviated protocol (AP), consisting of only one pre-
and one postcontrast acquisition and their derived images (first postcontrast subtracted …

Purpose To investigate the utility and accuracy of breast magnetic resonance (MR) imaging
as a supplemental screening tool in women at average risk for breast cancer and to …

This paper summarizes information about breast MRI to be provided to women and referring
physicians. After listing contraindications, procedure details are described, stressing the …